Magnetically stimulated breast cancer nanomedicines

Shubhangi Shirsat, Vijaykumar Jadhav, Rajaram S. Mane

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


This chapter provides details on magnetically stimuli-responsive nanomedicine as targeted delivery of a therapeutic agent for breast cancer, which is an important aspect of nanomedicines. Stimuli responsive magnetic drug delivery exhibits great superiority for reversal of multiple drugs resistance in breast cancer. Nanomedicines are desirable for achieving site-specific accumulation and triggered drug release in response to external magnetic stimuli.
Original languageAmerican English
Title of host publicationExternal Field and Radiation Stimulated Breast Cancer Nanotheranostics
PublisherIOP Publishing Ltd.
Pages4-1 to 4-26
StatePublished - 1 Jan 2019


Dive into the research topics of 'Magnetically stimulated breast cancer nanomedicines'. Together they form a unique fingerprint.

Cite this